Skip to Content
Epizyme Logo
Contact

Site - Header Menu

  • About
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Collaborations & Partnerships
  • Science
    • Epigenetic Scientific Platform
    • Preclinical Discovery Programs
    • Publications & Presentations
  • Clinical Development
    • Clinical Programs
    • Clinical Trials
    • Expanded Access Policy
    • Investigator Sponsored Trials
    • Medical Education & Sponsorship
  • Medicines
  • Investors & Media
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
      • Quarterly Results
      • Annual Report & Proxy
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Corporate Governance Documents
    • Resources
  • Careers

Investors & Media

Site - Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Annual Report & Proxy
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Analyst Coverage
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Corporate Governance Documents
  • Resources
    • Investor FAQs
    • Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
Jun 15, 2021
Document Date
Jun 11, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Epizyme, Inc.
Issuer
Epizyme, Inc.
Filer
Giordano Michael F

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Site - Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Annual Report & Proxy
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Analyst Coverage
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Corporate Governance Documents
  • Resources
    • Investor FAQs
    • Contact

Site - Shareholder Tools

Print Page
Email Alerts
  • Home
  • Privacy Policy
  • Terms of Use
  • Site Map
  • Contact
© 2022 Epizyme, Inc. - All Rights Reserved
▲